Cancer Research The Future of Cancer Research: Science and Patient Impact  09 AM Call for Abstracts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 48, 4382-4388, August 1, 1988]
© 1988 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fodstad, O.
Right arrow Articles by Pihl, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fodstad, O.
Right arrow Articles by Pihl, A.

Extrapulmonary, Tissue-specific Metastasis Formation in Nude Mice Injected with FEMX-I Human Melanoma Cells1

Øystein Fodstad2, Inge Kjønniksen, Steinar Aamdal, Jahn M. Nesland, Michael R. Boyd and Alexander Pihl

Department of Tumor Biology [Ø. F., I. K.], Department of Biochemistry [S. A., A. P.], and Department of Pathology [J. M. N.], Institute for Cancer Research, The Norwegian Radium Hospital, 0310 Oslo 3, Norway; and Developmental Therapeutics Program, Division of Cancer Treatment, National Cancer Institute, NIH, Bethesda, Maryland [M. R. B.]

FEMX-I human malignant melanoma cells, originating from a lymph node metastasis in a patient, uniquely and selectively produced extrapulmonary metastases after i.v. injection of cells prepared from xenografts into adult, nude mice. After a lag time of approximately 50 days, metastases were observed in s.c. sites at the back and front of the neck, and in axilla and inguinal regions. Tumor colony formation in lungs were never detected. The interscapular tumors showed a close relationship to brown fat, partly infiltrating this tissue, whereas the other s.c. tumors seemed to be localized to lymph nodes. Mesenterial and mediastinal lymph node metastases were frequently found, together with retroperitoneal tumors along the spine. The normal cells of the adrenal medulla were often replaced by melanoma cells, whereas the cortical tissue was not affected. The conclusion that FEMX-I cells possess an inherent ability for tissue-specific metastasis formation is supported by the metastatic pattern seen after i.p. and intrasplenic injection, as well as after inoculation of the cells in the footpads of the mice. The relatively slowly growing FEMX-I tumors showed the same differentiated morphology as the patient's tumor, independent of the site of growth and the number of passages in the animals. The FEMX-I tumor was easily established as a cell line in vitro. Such cells showed a strongly reduced metastatic capacity, indicating that the in vitro growth conditions had induced alterations in the FEMX-I cells influencing their ability to form site-specific metastases, changes that were shown to be reversible. It is suggested that structures on the surface of the tumor cells, as well as growth factors in the host tissues, may be of importance for the observed tissue specificity. The FEMX-I melanoma, which, as a human tumor in nude mice, has a unique metastatic pattern, offers possibilities for investigating mechanisms involved in site-specific metastasis formation, as well as for testing effects of antimetastatic, chemotherapeutic, and immunotherapeutic agents against human extrapulmonary micro- and macrometastases.

1 Supported by the Norwegian Cancer Society.

2 To whom requests for reprints should be addressed, at Department of Tumor Biology, Institute for Cancer Research, Montebello 0310, Oslo 3, Norway.

Received 2/ 9/88. Revised 4/26/88. Accepted 5/ 3/88.




This article has been cited by other articles:


Home page
Cancer Res.Home page
T. Ju, G. S. Lanneau, T. Gautam, Y. Wang, B. Xia, S. R. Stowell, M. T. Willard, W. Wang, J. Y. Xia, R. E. Zuna, et al.
Human Tumor Antigens Tn and Sialyl Tn Arise from Mutations in Cosmc
Cancer Res., March 15, 2008; 68(6): 1636 - 1646.
[Abstract] [Full Text] [PDF]


Home page
Vet PatholHome page
P. Labelle and H. E. V. De Cock
Metastatic Tumors to the Adrenal Glands in Domestic Animals
Vet. Pathol., January 1, 2005; 42(1): 52 - 58.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
K.-i. Kozaki, O. Miyaishi, T. Tsukamoto, Y. Tatematsu, T. Hida, T. Takahashi, and T. Takahashi
Establishment and Characterization of a Human Lung Cancer Cell Line NCI-H460-LNM35 with Consistent Lymphogenous Metastasis via Both Subcutaneous and Orthotopic Propagation
Cancer Res., May 1, 2000; 60(9): 2535 - 2540.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1988 by the American Association for Cancer Research.